BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20547186)

  • 1. High yield synthesis, purification and characterisation of the RNase L activators 5'-triphosphate 2'-5'-oligoadenylates.
    Morin B; Rabah N; Boretto-Soler J; Tolou H; Alvarez K; Canard B
    Antiviral Res; 2010 Sep; 87(3):345-52. PubMed ID: 20547186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.
    Ibsen MS; Gad HH; Thavachelvam K; Boesen T; Desprès P; Hartmann R
    J Virol; 2014 Dec; 88(24):14222-31. PubMed ID: 25275129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic synthesis of (2'-5')-linked oligoadenylates on a preparative scale.
    Samanta H; Lengyel P
    Methods Enzymol; 1986; 119():516-21. PubMed ID: 3762408
    [No Abstract]   [Full Text] [Related]  

  • 4. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
    Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
    Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme assays for synthesis and degradation of 2-5As and other 2'-5' oligonucleotides.
    Poulsen JB; Kjær KH; Justesen J; Martensen PM
    BMC Biochem; 2015 Jun; 16():15. PubMed ID: 26113370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule activators of RNase L with broad-spectrum antiviral activity.
    Thakur CS; Jha BK; Dong B; Das Gupta J; Silverman KM; Mao H; Sawai H; Nakamura AO; Banerjee AK; Gudkov A; Silverman RH
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9585-90. PubMed ID: 17535916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNase L plays a role in the antiviral response to West Nile virus.
    Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
    J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
    Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
    Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2- and 8-azido photoaffinity probes. 1. Enzymatic synthesis, characterization, and biological properties of 2- and 8-azido photoprobes of 2-5A and photolabeling of 2-5A binding proteins.
    Suhadolnik RJ; Karikó K; Sobol RW; Li SW; Reichenbach NL; Haley BE
    Biochemistry; 1988 Nov; 27(24):8840-6. PubMed ID: 3242613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2'-phosphodiesterase and 2',5'-oligoadenylate synthetase activities in the lowest metazoans, sponge [porifera].
    Saby E; Poulsen JB; Justesen J; Kelve M; Uriz MJ
    Biochimie; 2009; 91(11-12):1531-4. PubMed ID: 19665065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
    Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
    Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic synthesis of plant oligoadenylates in vitro.
    Devash Y; Sela I; Suhadolnik RJ
    Methods Enzymol; 1986; 119():752-8. PubMed ID: 3155418
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell viability and the (2',5')oligo(A)-RNase L pathway in human colon carcinoma cells treated with human interferons and double-stranded RNA.
    Chapekar MS; Glazer RI
    Prog Clin Biol Res; 1985; 202():377-84. PubMed ID: 2421317
    [No Abstract]   [Full Text] [Related]  

  • 14. RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.
    Madden JC; Cui D; Brinton MA
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
    Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photolabeling of the enzymes of the 2-5A synthetase/RNase L/p68 kinase antiviral systems with azido probes.
    Suhadolnik RJ
    Prog Mol Subcell Biol; 1994; 14():260-75. PubMed ID: 7520331
    [No Abstract]   [Full Text] [Related]  

  • 17. The Many Faces of Oligoadenylate Synthetases.
    Sarkar SN; Harioudh MK; Shao L; Perez J; Ghosh A
    J Interferon Cytokine Res; 2023 Nov; 43(11):487-494. PubMed ID: 37751211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease.
    Karikó K; Sobol RW; Suhadolnik L; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W
    Biochemistry; 1987 Nov; 26(22):7127-35. PubMed ID: 3427062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
    Ueno Y; Ishihara S; Ito Y; Kitade Y
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.
    Sánchez-Tacuba L; Rojas M; Arias CF; López S
    J Virol; 2015 Dec; 89(23):12145-53. PubMed ID: 26401041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.